Is Optum a subsidiary of UnitedHealth Group?

Optum is not a separate legal subsidiary but a brand platform within UnitedHealth Group, Inc.'s corporate structure. The three Optum segments (Optum Health, Optum Insight, and Optum Rx) operate as divisions or subsidiaries of UnitedHealth Group. Optum was formed in 2011 when UnitedHealth Group consolidated its existing pharmacy and care delivery services under a single brand. The Optum platform generated $270.6 billion in combined revenues in fiscal year 2025.

Is Optum publicly traded?

Optum is not publicly traded as a separate entity. Its parent company, UnitedHealth Group, Inc., trades on the New York Stock Exchange under the ticker symbol UNH. UnitedHealth Group reported total revenues of $447.6 billion in fiscal year 2025. There have been periodic discussions about whether UnitedHealth Group might spin off Optum as an independent company, but no such transaction has been announced as of August 2026.

When was Optum formed?

Optum was formed in 2011 when UnitedHealth Group consolidated its existing pharmacy and care delivery services under a single unified brand. The consolidation brought together businesses that had been operating separately within UnitedHealth Group, including Ingenix (health data analytics, renamed Optum Insight), the company's pharmacy benefits management operations (renamed Optum Rx), and its care delivery businesses (renamed Optum Health).

Who is the CEO of UnitedHealth Group?

Stephen Hemsley has served as CEO of UnitedHealth Group since May 2025, when Andrew Witty stepped down. Hemsley previously served as CEO from 2006 to 2017 and joined the company as COO in 1997. He has remained chairman of the board throughout.

Healthcare & Pharmaceuticals

Who Owns Optum?

Q: What happened with the Change Healthcare cyberattack?

In February 2024, Change Healthcare, an Optum Insight subsidiary acquired by UnitedHealth Group in 2022 for approximately $13 billion, suffered a ransomware cyberattack attributed to the ALPHV/BlackCat group. The attack disrupted healthcare payment processing across the United States for several weeks, affecting thousands of hospitals, pharmacies, and healthcare providers. UnitedHealth Group paid a ransom and spent hundreds of millions of dollars on remediation and support for affected providers. In 2025, the company reported $799 million in direct response costs related to the cyberattack.

Optum is owned by UnitedHealth Group, Inc. (NYSE: UNH), a publicly traded American healthcare company headquartered in Minnetonka, Minnesota. Optum was formed in 2011 when UnitedHealth Group consolidated its existing pharmacy and care delivery services under a single brand. Optum operates through three segments: Optum Health (care delivery, $102.0 billion), Optum Insight (data analytics and technology, $19.4 billion), and Optum Rx (pharmacy benefits management, $154.7 billion). In fiscal year 2025, Optum generated combined revenues of $270.6 billion, representing more than 60% of UnitedHealth Group's total $447.6 billion in revenues. UnitedHealth Group is led by CEO Stephen Hemsley, who returned to the role in May 2025.

Parent Company

UnitedHealth Group

Founded

2011

Status

Publicly Traded

Headquarters

Minnetonka, Minnesota, USA

Optum Timeline

1977

UnitedHealth Group

Parent company established in Minnetonka, Minnesota, USA

Company Founded

2011

Optum

Founded by UnitedHealth Group (internal consolidation)

Founded

premiummass marketGlobalall-agesesg reportingOfficial Website

Who Owns Optum?

Parent Company: UnitedHealth Group
Ownership Type: Wholly owned
Company Type: Publicly Traded
Stock Ticker: NYSE: UNH

Brand	Parent Company	Ownership Type
Optum	UnitedHealth Group	Wholly owned

Where to Buy

Disclosure: We may earn commission from purchases

Optum on Amazon

History of Optum

Founded: 2011
Founders: UnitedHealth Group (internal consolidation)

Optum's history begins with the individual businesses that were consolidated under the Optum brand in 2011. UnitedHealth Group had been building healthcare services capabilities for many years before the Optum brand was created, through a combination of organic development and strategic acquisitions.

UnitedHealth Group's pharmacy benefits management business, which became Optum Rx, had roots in the company's earlier pharmacy services operations. The company's health information technology business, which became Optum Insight, was built through acquisitions including the purchase of Ingenix, a healthcare data and analytics company, which UnitedHealth Group had operated since the 1990s. Ingenix was renamed Optum Insight when the Optum brand was launched in 2011.

The Optum brand was formally created in 2011 when UnitedHealth Group merged its existing pharmacy and care delivery services into a single unified platform. The consolidation was intended to create a more coherent healthcare services business that could compete more effectively with other large healthcare services companies and generate synergies across its different service lines.

Following the 2011 brand launch, Optum grew rapidly through a series of significant acquisitions. The company acquired Catamaran Corporation, a pharmacy benefits management company, in 2015 for approximately $12.8 billion, substantially expanding Optum Rx's scale and capabilities. The Catamaran acquisition made Optum Rx one of the three largest pharmacy benefits managers in the United States, alongside CVS Caremark and Express Scripts.

Optum continued its acquisition strategy in subsequent years, purchasing DaVita Medical Group in 2019 for approximately $4.9 billion, which significantly expanded Optum Health's physician and care delivery capabilities. The DaVita Medical Group acquisition gave Optum a large network of primary care physicians and medical groups, accelerating the company's strategy of providing direct patient care rather than solely managing healthcare benefits.

In 2022, UnitedHealth Group completed the acquisition of Change Healthcare, a healthcare technology company, for approximately $13 billion. Change Healthcare was integrated into Optum Insight, adding significant healthcare payment processing and data analytics capabilities. In February 2024, Change Healthcare suffered a ransomware attack that disrupted healthcare payment processing across the United States for several weeks, affecting thousands of hospitals, pharmacies, and healthcare providers. The attack was attributed to the ALPHV/BlackCat ransomware group.

In 2023, UnitedHealth Group announced that it would acquire Amedisys, a home health and hospice company, for approximately $3.3 billion, further expanding Optum Health's care delivery capabilities. The acquisition faced regulatory scrutiny from the Department of Justice, which filed suit to block the deal on antitrust grounds. The acquisition was ultimately terminated in 2024 following the DOJ's legal challenge.

In 2025, Optum's three segments generated combined revenues of $270.6 billion, up from $257 billion in 2024. Optum Rx grew 16% to $154.7 billion, driven by growth in pharmacy services and volume growth from new and existing clients. Optum Health generated $102.0 billion, and Optum Insight generated $19.4 billion, up 4% from 2024.

In May 2025, CEO Andrew Witty stepped down and Stephen Hemsley returned as CEO. On January 1, 2026, UnitedHealth Group realigned Optum Financial, including Optum Bank, from Optum Health into Optum Insight, expanding the division's consumer-directed healthcare account capabilities. In July 2026, Optum Insight completed its acquisition of Alegeus Technologies, further expanding its consumer-directed healthcare account platform.

UnitedHealth Group also completed the sale of its Optum UK business in 2026, with $400 million in net proceeds committed to the United Health Foundation.

About UnitedHealth Group

UnitedHealth Group operates through two primary platforms that work together to deliver comprehensive healthcare solutions: UnitedHealthcare and Optum. This integrated business model enables the company to serve the entire healthcare continuum, from insurance coverage to direct healthcare delivery and technology services, creating synergies that enhance both quality and efficiency.

UnitedHealthcare represents the company's health insurance and benefits division, providing coverage to individuals, employers, and government-sponsored programs including Medicare and Medicaid. In 2025, UnitedHealthcare served 49.8 million consumers and achieved revenues of $344.9 billion, representing 16% growth year-over-year. The division operates through multiple business segments including individual and family plans, employer-sponsored coverage, Medicare Advantage plans, and Medicaid managed care programs.

UnitedHealthcare's success stems from its extensive provider networks, innovative benefit designs, and focus on value-based care models. The company has developed sophisticated approaches to care coordination, preventive health programs, and chronic disease management that improve health outcomes while managing costs effectively. UnitedHealthcare's market leadership position enables it to negotiate favorable terms with healthcare providers and develop innovative insurance products that meet evolving consumer needs.

Optum delivers comprehensive healthcare services and technology solutions through three main segments that support the entire healthcare ecosystem:

Optum Health provides direct patient care and health services, operating clinics, surgical centers, and home health services. The segment employs healthcare professionals including physicians, nurses, and care coordinators who deliver integrated care to patients across various settings. Optum Health focuses on value-based care models that align financial incentives with health outcomes, creating more efficient and effective healthcare delivery systems.

Optum Insight offers data analytics, consulting, and technology services to healthcare organizations, payers, and life sciences companies. The segment leverages UnitedHealth Group's vast healthcare data assets to provide insights that improve clinical outcomes, reduce costs, and enhance operational efficiency. Optum Insight's services include population health management, revenue cycle optimization, and healthcare technology implementation.

Optum Rx manages pharmacy benefits for millions of people, negotiating with pharmaceutical manufacturers and managing prescription drug programs. In 2025, Optum Rx achieved 15% revenue growth, demonstrating strong performance in the pharmacy benefits management market. The segment combines purchasing power with clinical expertise to optimize medication therapy, improve adherence, and manage drug costs effectively.

UnitedHealth Group's integrated business model creates significant competitive advantages. The company's ability to combine insurance coverage with direct healthcare delivery enables better care coordination, improved health outcomes, and more efficient resource utilization. This integration also provides valuable data insights that inform product development, care management programs, and operational improvements.

In 2025, UnitedHealth Group demonstrated exceptional financial performance with consolidated revenues of $447.6 billion, representing 12% growth year-over-year. The company's adjusted earnings from operations reached $21.7 billion, reflecting strong operational execution despite challenges including cyberattack-related costs and business restructuring charges.

In Q2 2026, UnitedHealth Group reported revenues of $112.0 billion and earnings from operations of $8.0 billion, with net margin of 4.9%. Cash flows from operations were $11.1 billion, or 1.9 times net income. UnitedHealthcare served 48.5 million consumers (down from 49.8 million in 2025) and reported Q2 2026 revenues of $86.0 billion with earnings of $3.9 billion. Optum supported over 120 million consumers and generated Q2 2026 revenues of $65.7 billion with earnings of $4.0 billion, representing 160 basis points of margin expansion year over year.

The company's financial metrics demonstrate operational efficiency and strong cash generation. UnitedHealth Group achieved cash flows from operations of $19.7 billion in 2025, representing 1.5 times net income. The company maintains a debt-to-capital ratio of 41.2% (as of June 30, 2026) and targets a long-term ratio of 40.0%, reflecting prudent financial management.

UnitedHealth Group employs approximately 440,000 people worldwide, making it one of the largest employers in the healthcare industry. The company's workforce includes healthcare professionals, technology specialists, data analysts, and business professionals who support the company's integrated healthcare delivery model.

Looking toward 2026, UnitedHealth Group initially established revenue guidance greater than $439.0 billion (a 2% decline reflecting divestitures and membership reduction) and adjusted earnings outlook greater than $17.75 per share. After strong Q2 2026 results, the company raised its full-year 2026 guidance to adjusted net earnings of $19.50 to $20.00 per share, with earnings from operations greater than $25.2 billion. The company expects operating earnings from UnitedHealthcare to exceed $12 billion, Optum Health to exceed $2.2 billion, Optum Insight to exceed $4.9 billion, and Optum Rx to exceed $6.25 billion. Cash flows from operations are expected to be approximately $24 billion, with share repurchases of at least $5 billion.

Founded: 1977
Headquarters: Minnetonka, Minnesota, USA
Company Type: Publicly Traded
Stock: NYSE: UNH
Revenue: $447.6 billion (FY2025); ~$439 billion (FY2026 guidance)
Employees: approximately 440,000

Visit UnitedHealth Group website

View full company profile for UnitedHealth Group

Where Is Optum Made / Based?

Headquarters: Minnetonka, Minnesota, USA
Manufacturing / Operations: United States

Optum Categories & Tags

Healthcare Services Health Technology Pharmacy Benefits Data Analytics Unitedhealth Group American Brand

Optum Sustainability & Ethics

Optum operates under UnitedHealth Group's sustainability framework, which addresses environmental responsibility, ethical business practices, and social impact across the healthcare industry.

ESG Reporting: Optum participates in UnitedHealth Group's ESG reporting framework, following Sustainability Accounting Standards Board (SASB) guidelines for consistent disclosure of environmental, social, and governance information. The company has appointed a Chief Sustainability Officer to oversee sustainability initiatives.

Health System Improvement: Optum's core mission focuses on building a simpler, more consumer-oriented health system to help ensure everyone has access to high-quality, affordable healthcare. The company's "Built for Better Health" initiative serves as the foundation for long-term growth.

Responsible Business Practices: Optum maintains ethical standards in healthcare delivery, data management, and business operations. The company adheres to healthcare compliance frameworks and ethical business practices that prioritize patient privacy, data security, and fair treatment of all stakeholders. Optum's response to the February 2024 Change Healthcare cyberattack included the establishment of a Temporary Funding Assistance Program to help healthcare providers bridge cash flow gaps during the disruption.

Community Health Engagement: Optum maintains community engagement programs that support healthcare accessibility, preventive care initiatives, and community wellness programs. The company's services extend beyond its insured members to serve external clients including other health insurers, employers, government agencies, and healthcare providers.

Environmental Impact Reduction: As part of UnitedHealth Group's broader sustainability efforts, Optum has implemented environmental impact reduction initiatives across its operations, including energy-efficient facilities and renewable energy sources for its data centers and office locations.

Awards & Recognition

Optum Insight's AI-enabled products, including autonomous coding and digital prior authorization tools, have received attention in the healthcare technology industry in 2025 and 2026. The division's launch of these AI products has been noted by healthcare IT publications as a step toward reducing administrative burden in healthcare operations.

Optum Health's integrated care delivery model has received recognition from healthcare industry organizations for improving care coordination and patient outcomes. The company's physician group operations and care management programs have been acknowledged for demonstrating improvements in healthcare quality metrics compared to traditional fee-for-service models.

Optum Rx's pharmacy benefits management services have received recognition for innovation in medication management and cost containment strategies. The company's 1.66 billion adjusted scripts processed in fiscal year 2025 demonstrate the scale and efficiency of its pharmacy operations.

Optum's response to the February 2024 Change Healthcare cyberattack received recognition from healthcare industry organizations for crisis management and provider support. The company's establishment of the Temporary Funding Assistance Program, which advanced over $2 billion in payments to affected healthcare providers, was noted for maintaining healthcare system stability during the disruption.

Optum Recalls & Controversies

Optum has faced several significant challenges and controversies, particularly related to the February 2024 Change Healthcare cyberattack, regulatory scrutiny, and the complex dynamics of integrated healthcare delivery.

Change Healthcare Cyberattack (February 2024): The most significant challenge in Optum's history occurred in February 2024 when Change Healthcare, an Optum Insight subsidiary acquired for $13 billion in 2022, suffered a ransomware cyberattack attributed to the ALPHV/BlackCat group. The attack disrupted healthcare payment processing across the United States for several weeks, affecting thousands of hospitals, pharmacies, and healthcare providers. In 2025, the company reported $799 million in direct response costs related to the cyberattack. The incident led to congressional hearings and increased regulatory scrutiny.

Regulatory Scrutiny and Antitrust Concerns: Optum's vertical integration of insurance (UnitedHealthcare) and healthcare services has attracted increasing regulatory scrutiny from federal agencies. The Department of Justice successfully challenged UnitedHealth Group's proposed $3.3 billion acquisition of Amedisys in 2024 on antitrust grounds, signaling increased regulatory oversight of Optum's expansion through acquisitions.

Pharmacy Benefits Management Controversies: Optum Rx's role as a pharmacy benefits manager has been the subject of congressional scrutiny regarding drug pricing practices, rebate arrangements with pharmaceutical manufacturers, and potential conflicts of interest. Lawmakers have questioned whether PBMs create incentives that favor higher-priced medications over more affordable alternatives.

Leadership Transition: In May 2025, CEO Andrew Witty stepped down and Stephen Hemsley returned as CEO. The transition occurred amid government investigations, higher than expected medical costs, and public scrutiny following the December 2024 murder of UnitedHealthcare CEO Brian Thompson. UnitedHealth Group also withdrew its 2025 financial outlook at the time of the leadership change.

Data Privacy and Security Concerns: Beyond the Change Healthcare cyberattack, Optum faces ongoing challenges related to healthcare data privacy and security. The company's extensive collection and analysis of healthcare data creates inherent privacy risks, and Optum must navigate complex regulatory requirements under HIPAA and other healthcare privacy laws.

Market Position and Competition Pressures: Optum operates in intensely competitive healthcare services markets, facing pressure from other large healthcare companies including CVS Health, Humana, and various specialized healthcare technology companies. The company's dominant market position in pharmacy benefits management and healthcare payment processing has attracted regulatory attention regarding market concentration.

Optum Ownership: Pros & Cons

Advantages

+Optum's scale across pharmacy benefits, care delivery, and health technology creates significant competitive advantages, as the combined platform can offer integrated solutions that smaller, specialized competitors cannot match
+UnitedHealthcare's 49.8 million consumers in 2025 provide Optum's businesses with a large captive customer base that generates predictable revenue without requiring competitive bidding for each contract
+Optum Rx's 1.66 billion adjusted scripts processed in 2025 give the pharmacy benefits management business significant purchasing leverage with pharmaceutical manufacturers, enabling competitive drug pricing for clients
+Optum Insight's Change Healthcare acquisition provides the business with a dominant position in healthcare payment processing infrastructure that is deeply embedded in the U.S. healthcare system
+UnitedHealth Group's $447.6 billion in 2025 revenues provides Optum with investment capacity for technology development, acquisitions, and geographic expansion that smaller healthcare services companies cannot match

Considerations

-The February 2024 cyberattack on Change Healthcare, an Optum Insight subsidiary, disrupted healthcare payment processing across the United States for several weeks and exposed significant cybersecurity vulnerabilities in Optum's technology infrastructure
-Optum's vertical integration of insurance (UnitedHealthcare) and healthcare services (Optum) has attracted increasing regulatory scrutiny, with concerns that the combined entity has financial incentives to direct patients toward Optum's services even when alternatives might offer better outcomes
-The Department of Justice's successful challenge to UnitedHealth Group's proposed acquisition of Amedisys in 2024 signals increased antitrust scrutiny of Optum's continued expansion through acquisitions
-Optum Rx's role as a pharmacy benefits manager has been the subject of congressional scrutiny regarding drug pricing practices, rebate arrangements with pharmaceutical manufacturers, and the potential for conflicts of interest
-The 2026 outlook projects a revenue decline to approximately $439 billion for UnitedHealth Group, reflecting membership attrition and operational right-sizing that could affect Optum's growth trajectory

Frequently Asked Questions About Optum

Sources & Further Reading

Competitors to Optum

These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.

Brand	Parent Company	Country	Founded	Market Position	Primary Market	Gender Target
Express Scripts	Cigna	USA	1986	Mass market	United states	All-ages
Lash Group	Cencora	USA	1989	Mass market	Global	All-ages
Verily	Alphabet	USA	2015	Premium	Global	All-ages
Optum InsightSister Brand	Unitedhealth Group	USA	2011	Premium	United states	All-ages